Clinical trials
Phase 1/2 Recurrence trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 15 |
| Terminated | 12 |
| Completed | 6 |
| Active, not recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Therapeutic Advances in Childhood Leukemia Consortium | 3 |
| Celgene | 2 |
| Hoffmann-La Roche | 2 |
| Novartis Pharmaceuticals | 2 |
| Allogene Therapeutics | 1 |
| Amgen | 1 |
| Aptose Biosciences Inc. | 1 |
| Australian & New Zealand Children's Haematology/Oncology Group | 1 |
| BeOne Medicines | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 36 |
| Multiple Myeloma | 8 |
| Neoplasms | 7 |
| Lymphoma | 6 |
| Leukemia | 4 |
| Leukemia, Myeloid, Acute | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Neoplasm Metastasis | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.